Literature DB >> 1714579

Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.

K Nishida1, K Mihara, T Takino, S Nakane, Y Takakura, M Hashida, H Sezaki.   

Abstract

The effect of electric charge on the hepatic disposition of macromolecules was studied in the rat. Charged derivatives of dextran (T-70) and bovine serum albumin (BSA), mitomycin C-dextran conjugates (MMC-D), and lactosaminated BSA (Lac-BSA) were employed as model macromolecules. After intravenous injection, cationic macromolecules were rapidly eliminated from plasma because of their extensive hepatic uptake, while anionic and neutral macromolecules were slowly eliminated. Cationic macromolecules were recovered from parenchymal and nonparenchymal hepatic cells at a cellular uptake (per unit cell number) ratio of 1.4-3.2, while that of Lac-BSA was 14. During liver perfusion using a single-pass constant infusion mode, cationic macromolecules were continuously extracted by the liver, with extraction ratios at steady-state (Ess) ranging between 0.03 and 0.54, whereas anionic and neutral macromolecules were almost completely recovered in the outflow at steady state. The Ess for cationized BSA (Cat-BSA) and cationic MMC-Dcat were concentration dependent and decreased at low temperatures and in the presence of colchicine and cytochalasin B. The possible participation of the internalization process in the uptake of cationic macromolecules by hepatocytes was suggested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714579     DOI: 10.1023/a:1015886708598

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Metabolism of insulin-I 131; studies in isolated, perfused rat liver and hindlimb preparations.

Authors:  G E MORTIMORE; F TIETZE; D STETTEN
Journal:  Diabetes       Date:  1959 Jul-Aug       Impact factor: 9.461

2.  Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver.

Authors:  K Sato; K Itakura; K Nishida; Y Takakura; M Hashida; H Sezaki
Journal:  J Pharm Sci       Date:  1989-01       Impact factor: 3.534

3.  Altered movement of endosomes in colchicine-treated cultured macrophages.

Authors:  A N Bhisey; J J Freed
Journal:  Exp Cell Res       Date:  1971-02       Impact factor: 3.905

4.  Disposition characteristics of macromolecules in tumor-bearing mice.

Authors:  Y Takakura; T Fujita; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

5.  Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat.

Authors:  M Hashida; A Kato; Y Takakura; H Sezaki
Journal:  Drug Metab Dispos       Date:  1984 Jul-Aug       Impact factor: 3.922

6.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

7.  The accumulation mechanism of cationic mitomycin C-dextran conjugates in the liver: in-vivo cellular localization and in-vitro interaction with hepatocytes.

Authors:  S Nakane; S Matsumoto; Y Takakura; M Hashida; H Sezaki
Journal:  J Pharm Pharmacol       Date:  1988-01       Impact factor: 3.765

8.  Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin C.

Authors:  T Kojima; M Hashida; S Muranishi; H Sezaki
Journal:  J Pharm Pharmacol       Date:  1980-01       Impact factor: 3.765

9.  Fluid endocytosis by rat liver and spleen. Experiments with 125I-labelled poly(vinylpyrrolidone) in vivo.

Authors:  J Munniksma; M Noteborn; T Kooistra; S Stienstra; J M Bouma; M Gruber; A Brouwer; D Praaning-van Dalen Dalen; D L Knook
Journal:  Biochem J       Date:  1980-11-15       Impact factor: 3.857

10.  Phagolysosome formation in normal and colchicine-treated macrophages.

Authors:  E L Pesanti; S G Axline
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.

Authors:  Wassana Wijagkanalan; Shigeru Kawakami; Mitsuru Hashida
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

Review 2.  Issues related to targeted delivery of proteins and peptides.

Authors:  Yingjuan Lu; Jun Yang; Emanuela Sega
Journal:  AAPS J       Date:  2006-07-21       Impact factor: 4.009

3.  Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.

Authors:  K Nishida; Y Eguchi; T Takino; Y Takakura; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

Review 4.  Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.

Authors:  Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

5.  Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system.

Authors:  M Yoshida; R I Mahato; K Kawabata; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

6.  Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.

Authors:  Shintaro Fumoto; Fumi Nakadori; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers.

Authors:  Rebecca A Herbertson; Niall C Tebbutt; Fook-Thean Lee; David J MacFarlane; Bridget Chappell; Noel Micallef; Sze-Ting Lee; Timothy Saunder; Wendie Hopkins; Fiona E Smyth; David K Wyld; John Bellen; Daryl S Sonnichsen; Martin W Brechbiel; Carmel Murone; Andrew M Scott
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

Review 8.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Authors:  Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

9.  The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Authors:  Emilia Sokolowska; Bartlomiej Kalaska; Kamil Kaminski; Alicja Lewandowska; Agnieszka Blazejczyk; Joanna Wietrzyk; Irena Kasacka; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

10.  Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.

Authors:  Hidemasa Katsumi; Jun-Ichi Sano; Makiya Nishikawa; Keiko Hanzawa; Toshiyasu Sakane; Akira Yamamoto
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.